6 November 2026
Latham & Watkins Advises Precision BioSciences on US$125 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Nathan Ajiashvili Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Peter Handrinos Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Jie Lin Nai | Latham & Watkins LLP | Associate | corporate | Not stated |
| Jessmine Lee | Latham & Watkins LLP | Associate | corporate | Not stated |
1 more lawyer on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 125m (US$125 million)
- What the figure measures
- Issue size
- Client
- Precision BioSciences, Inc.Issuer
- Counterparties
- First Light Asset Management (Investor)
MPM BioImpact (Investor)
Bleichroeder LP (Investor)
Lynx1 Capital Management (Investor)
Readout Capital (Investor)
Aberdeen Investments (Investor)
Driehaus Capital Management (Investor)